Our science
LaminarPace
Projects
News
Investors
About us

Presentations

Home » Investors » Presentations

“We’re drying biologics” – watch Ziccum CEO Ann Gidner present Ziccum and LaminarPace – our unique ambient drying technology for biopharmaceuticals – at BioStock Life Science Fall Summit 2022.

Contact

e-mail: info@ziccum.com

ZICCUM AB
Scheelevägen 22
223 63 LUND
Sweden

About us

Ziccum is developing LaminarPace^TM, a unique ambient drying method for biopharmaceuticals and vaccines based on mass transfer, not heat transfer. By reducing drying stress to the active ingredient, LaminarPace^TM uniquely enables particle-engineered, thermostable dry powder biopharmaceuticals which can be easily handled and transported and also are highly suitable for novel administration routes.

Subscribe

Receive company data continuously to your inbox